Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpinia zerumbet gel-cream for temporomandibular disorder symptoms
RBR-2rtpqt8Phase 2Not yet recruiting
- Sponsor
- Universidade Federal de Sergipe
- Start
- Sep 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in temporomandibular disorder (TMD) (5 arms), sponsored by Universidade Federal de Sergipe. Planned start Sep 2025; status: not yet recruiting.
02
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on RBR-2rtpqt8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2rtpqt8.